A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1. BUSINESS PetVivo Holdings, Inc. (the “Company,” “PetVivo,” “we” or “us) is an emerging biomedical device company focused on the manufacturing, commercialization, and licensing of innovative medical devices and therapeutics for animals. The Company has a pipeline of eighteen products for the treatment of animals and humans. A portfolio of twelve patents and six proprietary trade secrets protects the Company’s biomaterials, products, production processes and methods of use. The Company began commercialization of its lead product Spryng® with OsteoCushion® Technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses, in the second quarter of its fiscal year ended March 31, 2022. In August 2021, we received net proceeds of approximately $9.7 million in a registered public offering (“Public Offering”) of 2.5 million units at a public offering price of $4.50 per unit.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | 1.1M | - | - | - | - | - |
| Net Income | -10M | -8.4M | -11M | -8.7M | -5.0M | -3.5M |
| EPS | $-0.38 | $-0.41 | $-0.78 | $-0.85 | $-0.57 | $-0.57 |
| Free Cash Flow | 0 | -5.4M | -7.7M | -7.2M | -4.3M | -908K |
| ROIC | -193.4% | -156.1% | -1618.6% | - | - | - |
| Gross Margin | 66.0% | - | - | - | - | - |
| Debt/Equity | 0.00 | 0.07 | 0.01 | - | - | - |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -8.2M | -8.1M | -11M | -8.7M | -5.1M | -2.0M |
| Operating Margin | -735.9% | - | - | - | - | - |
| ROE | -302.1% | -342.5% | -1597.1% | - | - | - |
| Shares Outstanding | 35M | 20M | 14M | 10M | 9M | 6M |
PetVivo Holdings, Inc. passes 0 of 9 quality checks, indicating weak fundamentals.
PetVivo Holdings, Inc. (PETVW) has a 5-year average return on invested capital (ROIC) of -156.1%. This is below average and may indicate limited pricing power.
PetVivo Holdings, Inc. (PETVW) has a market capitalization of $945K. It is classified as a small-cap stock.
PetVivo Holdings, Inc. (PETVW) does not currently pay a regular dividend.
PetVivo Holdings, Inc. (PETVW) operates in the Surgical & Medical Instruments & Apparatus industry, within the Healthcare sector.
PetVivo Holdings, Inc. (PETVW) generated $-5 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
PetVivo Holdings, Inc. (PETVW) has a debt-to-equity ratio of 0.07. This indicates a conservatively financed balance sheet.
PetVivo Holdings, Inc. (PETVW) reported earnings per share (EPS) of $-0.41 in its most recent fiscal year.
PetVivo Holdings, Inc. (PETVW) has a return on equity (ROE) of -342.5%. A negative ROE may indicate losses or negative equity.
The Ledger Terminal provides 11 years of financial data for PetVivo Holdings, Inc. (PETVW), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
PetVivo Holdings, Inc. (PETVW) has a book value per share of $0.21, based on its most recent annual SEC filing.
No recent items.